[Optimal time for antiretroviral therapy of HIV infection: NA-ACCORD (North American AIDS cohort collaboration on research and design)].
Jensen
B
B
Klinik für Gastroenterologie, Hepatologie und Infektiologie, Universitätsklinikum Düsseldorf, Moorenstrasse 5, 40225, Düsseldorf, Deutschland.
Nitschmann
S
S
Häussinger
D
D
D000328:Adult; D044966:Anti-Retroviral Agents / Q000008:administration & dosage*; D018791:CD4 Lymphocyte Count; D015331:Cohort Studies; D015986:Confounding Factors, Epidemiologic; D004334:Drug Administration Schedule; D005260:Female; D006678:HIV / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D006801:Humans; D008297:Male; D008875:Middle Aged; D009656:North America; D016016:Proportional Hazards Models; D012367:RNA, Viral / Q000032:analysis; D012306:Risk; D016019:Survival Analysis
D044966:Anti-Retroviral Agents; D012367:RNA, Viral